Aromatase inhibitors for ovulation induction

Stefano Palomba

doi:10.1210/jc.2014-4235

Aromatase inhibitors for ovulation induction

Stefano Palomba

Research output: Contribution to journal › Article › peer-review

Abstract

Normogonadotropic anovulation, including polycystic ovary syndrome (PCOS), is one of the main causes of infertility. Recent meta-analysis and randomized controlled trial suggest the use of aromatase inhibitors (ie, letrozole) as effective drug and first-line treatment to restore fertility in these patients. The current manuscript will give a critical, provocative, and personal point of view on the topic.

Original language	English
Pages (from-to)	1742-1747
Number of pages	6
Journal	Journal of Clinical Endocrinology and Metabolism
Volume	100
Issue number	5
DOIs	https://doi.org/10.1210/jc.2014-4235
Publication status	Published - May 1 2015

ASJC Scopus subject areas

Biochemistry
Clinical Biochemistry
Endocrinology
Biochemistry, medical
Endocrinology, Diabetes and Metabolism
Medicine(all)

Access to Document

10.1210/jc.2014-4235

Cite this

@article{d66404f10d204d3598a3a6d62bbf37cf,

title = "Aromatase inhibitors for ovulation induction",

abstract = "Normogonadotropic anovulation, including polycystic ovary syndrome (PCOS), is one of the main causes of infertility. Recent meta-analysis and randomized controlled trial suggest the use of aromatase inhibitors (ie, letrozole) as effective drug and first-line treatment to restore fertility in these patients. The current manuscript will give a critical, provocative, and personal point of view on the topic.",

author = "Stefano Palomba",

year = "2015",

month = may,

day = "1",

doi = "10.1210/jc.2014-4235",

language = "English",

volume = "100",

pages = "1742--1747",

journal = "Journal of Clinical Endocrinology and Metabolism",

issn = "0021-972X",

publisher = "The Endocrine Society",

number = "5",

}

TY - JOUR

T1 - Aromatase inhibitors for ovulation induction

AU - Palomba, Stefano

PY - 2015/5/1

Y1 - 2015/5/1

N2 - Normogonadotropic anovulation, including polycystic ovary syndrome (PCOS), is one of the main causes of infertility. Recent meta-analysis and randomized controlled trial suggest the use of aromatase inhibitors (ie, letrozole) as effective drug and first-line treatment to restore fertility in these patients. The current manuscript will give a critical, provocative, and personal point of view on the topic.

AB - Normogonadotropic anovulation, including polycystic ovary syndrome (PCOS), is one of the main causes of infertility. Recent meta-analysis and randomized controlled trial suggest the use of aromatase inhibitors (ie, letrozole) as effective drug and first-line treatment to restore fertility in these patients. The current manuscript will give a critical, provocative, and personal point of view on the topic.

UR - http://www.scopus.com/inward/record.url?scp=84929378150&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84929378150&partnerID=8YFLogxK

U2 - 10.1210/jc.2014-4235

DO - 10.1210/jc.2014-4235

M3 - Article

C2 - 25710566

AN - SCOPUS:84929378150

VL - 100

SP - 1742

EP - 1747

JO - Journal of Clinical Endocrinology and Metabolism

JF - Journal of Clinical Endocrinology and Metabolism

SN - 0021-972X

IS - 5

ER -

Aromatase inhibitors for ovulation induction

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this